Abstract
Accurate prediction of cumulative COVID-19 infected cases is essential for effectively managing the limited healthcare resources, specifically in India. Historically, epidemiological models have helped control such epidemics. Those models need accurate past data to predict for future. However, for various reasons, we observe sudden drops and jumps in the number of daily reported COVID-19 infected cases on some days, not aligned with the overall trend. If we incorporate those observations in the training data, the model’s prediction accuracy may worsen, as they do not capture the correct trend in the training data. But it is not straightforward for the existing epidemiological models to decide a specific day as a sudden drop or jump. We propose an algorithm that automatically determines any drop or jump days in this work. Then, based on the overall trend in the data, we adjust the number of daily infected cases on those days and decide on the training data based on the adjusted observations. We have applied the proposed algorithm in a recently proposed modified Susceptible-Infected-Susceptible (SIS) to show that adjusted training data gives better prediction accuracy when jump and drop exist in the training data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Rashi Mohta, Prathapani Sravya would like to acknowledge Samsung Fellowship for this work. Palash Ghosh would like to acknowledge support by ICMR Centre for Excellence, Grant no. 5/3/8/20/2019-ITR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://www.covid19india.org/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
rashi{at}iitg.ac.in, prathapa{at}iitg.ac.in
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.